US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Algorae Pharmaceuticals Ltd (1AIOA) 銘柄情報

Algorae Pharmaceuticals Ltd (1AIOA)

0.001

0.00

( 0.00% )

更新日時： 09:00:00

Algorae Pharmaceuticals Ltd (1AIOA) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.001

出来高

0.00

平均取引量 (3 か月)

AUD 1,565,103

財務取引量

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

企業価値

25.462M

前日終値

0.001

始値

-

時刻

最終取引時間

-

VWAP

-

歳入

-

純利益

-1.01M

発行済株式数

2,025,570,988

浮動株比率 (%)

69.07%

機関投資家保有比率 (%)

2.02%

配当利回り

PER

-22.5

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-0

ベータ

-0.06

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatm... Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer’s disease; AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient for the treatment of cardiovascular disease, such as hypertension; and NTCELL, an alginate coated capsule product for the treatment of Parkinson’s disease. It is also developing AlgaraeOS in partnership with the University of New South Wales, a drug discovery platform that uses artificial intelligence protocols and big data analytics for drug discovery and development. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia. 詳細を表示

セクター

Health Care

業界

-

ウェブサイト

algoraepharma.com

本社

Melbourne, Australia

設立

1987

Algorae Pharmaceuticals Ltd is listed in the Health Care sector of the オーストラリア証券取引所 with ticker 1AIOA. The last closing price for Algorae Pharmaceuticals was AUD0. Over the last year, Algorae Pharmaceuticals shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Algorae Pharmaceuticals currently has 2,025,570,988 shares in issue. The market capitalisation of Algorae Pharmaceuticals is AUD2.03 million. Algorae Pharmaceuticals has a price to earnings ratio (PE ratio) of -22.50.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

1AIOA - Frequently Asked Questions (FAQ)

What is the current Algorae Pharmaceuticals Ltd share price?

The current share price of Algorae Pharmaceuticals Ltd is AUD 0.001

How many Algorae Pharmaceuticals Ltd shares are in issue?

Algorae Pharmaceuticals Ltd has 2,025,570,988 shares in issue

What is the market cap of Algorae Pharmaceuticals Ltd?

The market capitalisation of Algorae Pharmaceuticals Ltd is AUD 2.03M

What is the 1 year trading range for Algorae Pharmaceuticals Ltd share price?

Algorae Pharmaceuticals Ltd has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Algorae Pharmaceuticals Ltd?

The price to earnings ratio of Algorae Pharmaceuticals Ltd is -22.5

What is the registered address of Algorae Pharmaceuticals Ltd?

The registered address for Algorae Pharmaceuticals Ltd is Rialto South Tower, Melbourne, Victoria, 3000

What is the Algorae Pharmaceuticals Ltd website address?

The website address for Algorae Pharmaceuticals Ltd is algoraepharma.com

shajandr

shajandr 10分前

SAM ALTMAN = LIZZY HOLMES with better hair.

ron_66271

ron_66271 13分前

The Discovery Document by QE Proves RICO.

Project West.

The BOD was reviewed on the status of the project three times.
Therefore the BOD past and present are compliant with the project of Project West.

Has current JPM BOD voiced settlement and paym

Porch Honkey

Porch Honkey 16分前

When they are ready, there will be investors here that you have never seen before, gl.

LOB

Blaqclouds Wyoming

@blaqclouds_WY
#Blaqclouds • #DEFI💎 http://BLAQpay.io http://AplloNFT.io🔎• #NFT #WEB3 Dev • DM 📩 for Collab
Social Media InfluencerPAblaqclouds.io
Joined May 2020
1,260 Following
123.5K Followers

Juststoppingby

Juststoppingby 21分前

My AI responds to clarification on “EDGAR packages are being validated”.

When I say “EDGAR packages are being validated,” I’m talking about a very specific, very technical stage in the SEC-filing process — one that happens right before a delinquent filer begins submitting forms.

zakattack

zakattack 22分前

They put out a pr dec 2025 stating they would increase to 49% in gncp but no filings proving they actually did so sp again where is the proof pdiv paid anything or did anything for the land claims prove me wrong

nowwhat2

nowwhat2 25分前

xxxxxxxxxxxx wow

https://investorshub.advfn.com/uimage/uploads/2026/7/13/i[smibtc_july_12_2m_7pm_200_64_diag_point.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7/13/wtzkebtc_july_12_2m_9pm_update_200_64_point_tl.jpg

mikeo56

mikeo56 27分前

Smoking in Aussie land .
Up 30 %
Tomorrow in USA will be good.

choo choo trader

choo choo trader 30分前

Thanks for reposting it Striper, somehow I missed it when gdog initially posted it. That is about the most informative video I have seen so far laying out the whole risk/reward story of $NLST.

ron_66271

ron_66271 30分前

No The FDIC and JPM both Had a Claim Against $24 Billion.

Inflated claim of $27*2=$54.00 Billion against the Estate to make WMI as insolvent for the Senior Note holders when JPM controlled the BK process because invested in the Senior Notes of WMI with the takeover.

skitahoe

skitahoe 31分前

Doc, I've been saying this for ages, but not that the full EDEN based facility must be completed. I believe the UK and other countries would simply like to know it's close. They'd like to know the EDEN is making commercial quality vaccine and that it can be delivered in quantity, and they'd like t

FDA-agent-2

FDA-agent-2 35分前

nobody is getting paid here .no editiing or no research which cost money.

Johnnycombat10

Johnnycombat10 36分前

I see both sides of the debate . The company has every right to state their position just as you have your right to speak yours. But you have right to demand anything from anyone on this board. You have no rights other than the right to speak our mind. And I have the to tell you to pound salt. If I

AstroGuru64

AstroGuru64 37分前

The issue still lies with the Treasury Department.

FDA-agent-2

FDA-agent-2 40分前

too much fake news on facebook, yahoo,and youtube these. and tabloid news or censored news.
sites like google, yahoo. facebook cannot get the content for cheap anymore or they won't even license it to them, it used to be free or very cheap to promote their newsight but they don't nobody ever

Truthsocial

Truthsocial 42分前

Vivos Inc. received U.S. FDA approval for the Investigational Device Exemption (IDE) for RadioGel® on July 6, 2026, which permits the initiation of the first-in-human feasibility study at Mayo Clinic in Jacksonville, FL.

While the FDA IDE approval has been granted, the study protocol

gfp927z

gfp927z 43分前

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

uber darthium

uber darthium 43分前

DBSCAM’em

A Linda Poory SCAM for over 2 decades

Can’t wait to read that filing this week

Ought to make for some good SCAM reading

DBSCAM’em

Noted and Always Correct

zerosnoop

zerosnoop 44分前

All the GEMS & FACTS are in the latest 10Q filing. The PROVEN AOT is going GLOBAL.

We are now focusing on a potential sale of 150 units as an initial purchase order under the so-called Laksel LOI (discussed below). This represents a defined India focused initial program wit

gfp927z

gfp927z 45分前

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

raggi65

raggi65 46分前

Do you have a link to the discovery document filed by Quinn Emanuel?
825 pages – that sounds as though there might be plenty of useful arguments in there, and with a citable reference, they would be all the more compelling

juicyjuice10002

juicyjuice10002 48分前

Yes, Executive Order 14393 is widely expected to help Fannie Mae (FNMA) and Freddie Mac (FMCC) by laying the regulatory groundwork for their eventual exit from government conservatorship.

While much of the public text targets community banks, the order contains specific directives fo

chuck1418

chuck1418 52分前

volume is picking up and shares are turning over. this week could be a breakout if we can go and sustain doubles

DrivenByPain

DrivenByPain 54分前

$SNTX! LMMFAO! More Then Just Nice Volume Here My Boy .

Algorae Pharmaceuticals

Great Portland Estates (PK)

Affiliated Managers

US Bancorp Fund Services

US Dollar vs BYN

Day Hagan Smart Sector F...

First Australian Resources

Array Digital Infrastruc...

A Living Smart City Serv... (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。